Skip to main content

Liraglutide cut risk of microvascular renal complications by 22% in type 2 diabetes; no eye benefit

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Liraglutide cut risk of microvascular renal complications by 22% in type 2 diabetes; no eye benefit

User login

Username

Password

Reset your password

Type	Lead	score